India's Cohance Lifesciences falls after US FDA inspection at Telangana plant

Cohance Lifesciences

07/09/2026 09:56

** Shares of India's Cohance Lifesciences COHA.NS fall 2.1% to 447 rupees
** The drugmaker says the U.S. FDA inspected its formulation plant in Telangana's Shamshabad from August 27 to September 4
** Adds that inspection concluded with issuance of Form FDA 483 containing four observations
** Stock rated "sell" on average by 8 analysts; median PT is 440 rupees - LSEG-compiled data
** Stock down 15.4%, YTD


 (Reporting by Payel Das in Bengaluru)
 ((Payel.das@thomsonreuters.com))